Parent Involvement in Adolescent Obesity Treatment

Exclusion Criteria

• •Non-English speaking
• •Medical condition(s) that may be associated with unintentional weight change
• •Diabetes mellitus
• •Use of oral glucocorticoids, atypical antipsychotics, weight loss medications, or an investigational medication within 3 months of study participation
• •Use of a GLP-1 within 6 months of study participation
• •Use of Depo-Provera within 6 months of study participation
• •Medical condition(s) that may be negatively impacted by exercise
• •Psychiatric, cognitive, physical or developmental conditions that would impair the ability to complete assessments, participate in a group, or conduct physical activity
• •Reports of compensatory behaviors in the past 3 months
• •Current pregnancy or plan to become pregnant during study period
• •Previous participation in HM20010365, HM20003076, HM20005235 or HM20014304
• •Current participation in another weight loss program
• •Personal history of weight loss surgery
• •Severe depression
• •Clinically significant eating disorder
• •Change in dose of metformin, tricyclic antidepressants, selective serotonin uptake inhibitors, or stimulant medications within 3 months of study participation
• •Admission to a psychiatric hospital within the past year
• •Non-English speaking
• •Medical condition(s) that may be associated with unintentional weight change
• •Use of oral glucocorticoids, atypical antipsychotics, weight loss medications, or an investigational medication within 3 months of study participation
• •Use of a GLP-1 within 6 months of study participation with no T2D diagnosis; if T2D diagnosis, change in dose GLP-1 within 3 months of study participation
• •Use of Depo-Provera within 6 months of study participation
• •Psychiatric, cognitive, physical or developmental conditions that would impair the ability to complete assessments, participate in a group, or conduct physical activity
• •Reports of compensatory behaviors in the past 3 months
• •Current pregnancy, lactation, less than 6 months post-partum, or plan to become pregnant during study period
• •Previous participation in HM20010365, HM20003076, HM20005235 or HM20014304
• •Current participation in another weight loss program
• •Personal history of weight loss surgery
• •Severe depression
• •Clinically significant eating disorder
• •Change in dose of diabetes medications, tricyclic antidepressants, selective serotonin uptake inhibitors, or stimulant medications within 3 months of study participation
• •Admission to a psychiatric hospital within the past year